Skip to main content
. 2023 Feb 17;37(2):153–166. doi: 10.1007/s40290-023-00462-2

Table 1.

PICOS selection criteria

Criterium Inclusion
Population Children and adults with drug-induced HPL
Intervention Drug treatment known or suspected to induce HPL
Comparator Any or no comparator
Outcomes Clinical presentation, including symptoms and signs of druginduced HPL, such as reproductive dysfunction, sexual impairment, breast dysfunctions, abnormalities associated with chronic hypogonadism, behavioural and mood alterations
Long-term complications of drug-induced HPL
Study design

Interventional and non-interventional studies:

• Non-interventional/observational studies (prospective, retrospective, cross-sectional studies)

• Interventional studies (randomised and non-randomised clinical trials)

HPL hyperprolactinaemia, PICOS populations, interventions and comparators, outcomes, and study design